Technology
Health
Pharmaceutical

Spring Bank Pharmaceuticals

$9.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (0.94%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell SBPH and other stocks, options, ETFs, and crypto commission-free!

About

Spring Bank Pharmaceuticals, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. Read More The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.

Employees
29
Headquarters
Hopkinton, Massachusetts
Founded
2002
Market Cap
157.61M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
44.87K
High Today
$9.90
Low Today
$9.38
Open Price
$9.51
Volume
12.51K
52 Week High
$15.73
52 Week Low
$8.14

Collections

Technology
Health
Pharmaceutical
Banking
Medical
Biopharmaceutical
Therapy
Finance

News

Simply Wall StMar 21

Imagine Owning Spring Bank Pharmaceuticals (NASDAQ:SBPH) And Wondering If The 30% Share Price Slide Is Justified

While it may not be enough for some shareholders, we think it is good to see the Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) share price up 12% in a single quarter. But that doesn’t change the fact that the returns over the last year have been less than pleasing. The cold reality is that the stock has dropped 30% in one year, under-performing the market. Check out our latest analysis for Spring Bank Pharmaceuticals Spring Bank Pharmaceuticals hasn’t yet reported any revenue yet, so it’s as much a busi...

29
Seeking AlphaMar 11

Spring Bank Pharmaceuticals (SBPH) CEO Martin Driscoll on Q4 2018 Results - Earnings Call Transcript

Spring Bank Pharmaceuticals (NASDAQ:SBPH) Q4 2018 Earnings Conference Call March 11, 2019 8:00 AM ET Company Participants Jon Freve - CFO Martin Driscoll - President &CEO Conference Call Participants Mari Cross - Jeffries Ted Tenthoff - Piper Jaffray Katherine Xu - William Blair Operator Good morning, ladies and gentlemen, and welcome to the Spring Bank March 11 2019 Conference Call. Currently, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instr...

58
Seeking AlphaMar 11

Spring Bank Pharmaceuticals, Inc. 2018 Q4 - Results - Earnings Call Slides

The following slide deck was published by Spring Bank Pharmaceuticals, Inc. in conjunction with their 2018 Q4 earnings call. 1 45 Click to enlarge Notes:...

16

Earnings

-$0.93
-$0.66
-$0.38
-$0.11
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.57 per share
Actual
-$0.37 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.